secwatch / observer

Debt Financings

New loans, notes, and credit facilities disclosed under 8-K Items 2.03/2.04.

8-K items 2.03, 2.04 JSON
Enphys Acquisition Corp.

Enphys Acquisition Corp. amended loan of Not specified with Enphys Acquisition Sponsor LLC at Not specified maturing Extended to December 31, 2024.

“On March 1, 2024, Enphys Acquisition Corp. (the “Company”) and Enphys Acquisition Sponsor LLC, a Delaware limited liability company (the “Payee”) entered into a First Amendment to Promissory Note (the “Amendment”) to amend the promissory note issued by the Company to Payee on October 30, 2023 (the “2023 Promissory Note”) as described in the Current Report on Form 8-K filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) on October 30, 2023.”
BEEP Mobile Infrastructure Corp

Mobile Infrastructure Corp amended credit facility with KeyBank National Association maturing June 30, 2025.

“Pursuant to the Third Amendment, the parties agreed to extend the maturity date of the Credit Agreement to a maximum maturity date of June 30, 2025, subject to certain interest rate adjustments after the first extended maturity date of October 1, 2024, and certain further interest rate adjustments after the second extended maturity date of April 1, 2025.”
QTI QT IMAGING HOLDINGS, INC.

QT IMAGING HOLDINGS, INC. incurred convertible notes of $11,500,000 with Yorkville, Cable Car.

“In connection with the Closing, the Company issued $11,500,000 of convertible notes (the “ Convertible Notes ”) to Yorkville and Cable Car pursuant to the terms of the SEPA, the Yorkville Note, the Cable Car NPA, and the Cable Car Note.”
Vintage Wine Estates, Inc.

Vintage Wine Estates, Inc. amended revolving credit of $180 million with BMO Bank N.A..

“reduces the revolving commitments under the Loan Agreement from $200 million to $180 million”
Airspan Networks Holdings Inc.

Airspan Networks Holdings Inc. amended convertible notes.

“the Note Purchase Agreement (as amended by the NPA Amendment) and the convertible notes issued under the Note Purchase Agreement (the “Convertible Notes”) were modified to, among other things, (i) extend the waiver of certain potential prospective events of default under the Note Purchase Agreement in the limited manner set forth therein and (ii) the forbearance by the purchasers party to the NPA Amendment from exercising their rights and remedies as a result of certain potential prospective events of default under the Note Purchase Agreement in the limited manner set forth therein”
Airspan Networks Holdings Inc.

Airspan Networks Holdings Inc. incurred term loan of $750,000 with DBFIP ANI LLC at Base Rate or Adjusted Term SOFR plus between 9.00% and 14.00% per annum maturing December 30, 2024.

“The Fifth A&R Credit Agreement establishes a new delayed draw term loan commitment of $750,000 (the “Fifth Restatement Delayed Draw Term Loan”), which will accrue interest at a variable rate per annum equal to either the Base Rate (as defined in the Fifth A&R Credit Agreement) or the Adjusted Term SOFR (as defined in the Fifth A&R Credit Agreement), plus between 9.00% and 14.00% per annum”
Transphorm, Inc.

Transphorm, Inc. incurred term loan of $35.0 million delayed draw term loan facility with Renesas Electronics America Inc. at term SOFR for an interest period of 3 months plus 5.0% maturing the earliest to occur of (1) written demand from the Lender following the closing of the Merger, (2) if, on the date of the termination of the Merger Agreement.

“On March 1, 2024, Transphorm, Inc. (the “ Company ”) entered into a Credit and Security Agreement (the “ Credit Agreement ”), among the Company, Transphorm Technology, Inc., as guarantor (the “ Guarantor ”), and Renesas Electronics America Inc., as lender (the “ Lender ”). The Credit Agreement provides for a $35.0 million delayed draw term loan facility.”
ARDX ARDELYX, INC.

ARDELYX, INC. incurred term loan of $50.0 million with SLR Investment Corp. as collateral agent and the lenders listed in the agreement at 4.25% plus a SOFR value equal to 0.022% plus the 1-month CME Term SOFR reference maturing March 1, 2027.

“On March 1, 2024, Ardelyx, Inc. (the we, us, our) received $50.0 million of funding (Term C Loan) pursuant to the loan and security agreement entered into in February 2022 by and between us and SLR Investment Corp. as collateral agent (Agent) and the lenders listed in the agreement (collectively, the Lenders), and as amended in August 2022, February 2023 and October 2023 (collectively, the 2022 Loan Agreement).”
SONX Sonendo, Inc.

Sonendo, Inc. amended credit facility with Perceptive Credit Holdings III, LP.

“the Company entered to Amendment No. 3 (the "Amendment") to its Amended and Restated Credit Agreement and Guaranty, dated as of August 23, 2021, by and among the Company, the subsidiary guarantors named therein, the lenders party thereto and Perceptive Credit Holdings III, LP, as amended (the "Credit Agreement"). The Amendment amended the Credit Agreement to include a one-time $15.0 million principal repayment and initiate monthly principal repayments beginning in March 2024 along with modifications to certain other terms including revenue covenants.”
APLD Applied Digital Corp.

Applied Digital Corp. incurred loan of $16,000,000 with Cornerstone Bank at 8.590% per annum maturing March 1, 2029.

“the Lender loaned the principal amount of $16,000,000 to the Borrower with a maturity date of March 1, 2029”
Ayala Pharmaceuticals, Inc.

Ayala Pharmaceuticals, Inc. incurred convertible notes of additional $2.0 million with Israel Biotech Fund I, L.P., Israel Biotech Fund II, L.P., Arkin Bio Ventures L.P. and Biotel Limited.

“On March 1, 2024, the Company issued Senior Convertible Promissory Notes to the Noteholders (collectively, the “March 2024 Senior Convertible Notes”), in substantially the same form as the November 2023 Senior Convertible Notes, in connection with the loan by the Noteholders to the Company an additional $2.0 million, pursuant to their rights under the Side Letter Agreement (New Notes).”
ARMP Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals, Inc. incurred term loan of $35 million with Innoviva Strategic Opportunities LLC at 14.0% per annum maturing June 4, 2025.

“The Credit Agreement provides for a secured term loan facility in an aggregate amount of $35 million (the “Loan”) at an interest rate of 14.0% per annum, and has a maturity date of June 4, 2025.”
WOLF WOLFSPEED, INC.

WOLFSPEED, INC. incurred debt of $500 million with Renesas Electronics America Inc..

“On February 27, 2024, Renesas America completed an Additional Funding in an aggregate principal amount of $500 million based on a request delivered by the Company.”
RDN RADIAN GROUP INC

RADIAN GROUP INC incurred senior notes of $625 million aggregate principal amount at 6.200% maturing 2029.

“(EX-99.1) --- EX-99.1 Exhibit 99.1 OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION The estimated expenses incurred by the Company in connection with its issuance and sale of $625 million aggregate principal amount of 6.200% Senior Notes due 2029, are set forth in the following table: Securities and Exchange Commission Registration Fee $ 92,250 Legal Fees and”
FISV FISERV INC

FISERV INC incurred senior notes of $750,000,000 aggregate principal amount with U.S. Bank Trust Company, National Association at 5.450% per year maturing March 15, 2034.

“On March 4, 2024, Fiserv, Inc. (the “Company”) completed the public offering and issuance of $750,000,000 aggregate principal amount of its 5.150% Senior Notes due 2027 (the “2027 Notes”), $500,000,000 aggregate principal amount of its 5.350% Senior Notes due 2031 (the “2031 Notes”) and $750,000,000 aggregate principal amount of its 5.450% Senior Notes due 2034 (the “2034 Notes” and, together with the 2027 Notes and the 2031 Notes, the “Notes”).”
FISV FISERV INC

FISERV INC incurred senior notes of $500,000,000 aggregate principal amount with U.S. Bank Trust Company, National Association at 5.350% per year maturing March 15, 2031.

“On March 4, 2024, Fiserv, Inc. (the “Company”) completed the public offering and issuance of $750,000,000 aggregate principal amount of its 5.150% Senior Notes due 2027 (the “2027 Notes”), $500,000,000 aggregate principal amount of its 5.350% Senior Notes due 2031 (the “2031 Notes”) and $750,000,000 aggregate principal amount of its 5.450% Senior Notes due 2034 (the “2034 Notes” and, together with the 2027 Notes and the 2031 Notes, the “Notes”).”
FISV FISERV INC

FISERV INC incurred senior notes of $750,000,000 aggregate principal amount with U.S. Bank Trust Company, National Association at 5.150% per year maturing March 15, 2027.

“On March 4, 2024, Fiserv, Inc. (the “Company”) completed the public offering and issuance of $750,000,000 aggregate principal amount of its 5.150% Senior Notes due 2027 (the “2027 Notes”), $500,000,000 aggregate principal amount of its 5.350% Senior Notes due 2031 (the “2031 Notes”) and $750,000,000 aggregate principal amount of its 5.450% Senior Notes due 2034 (the “2034 Notes” and, together with the 2027 Notes and the 2031 Notes, the “Notes”).”
POTOMAC ELECTRIC POWER CO

POTOMAC ELECTRIC POWER CO incurred senior notes of $300 million at 5.500% per annum maturing March 15, 2054.

“(ii) $300 million aggregate principal amount of Pepco’s First Mortgage Bonds 5.500% Series due March 15, 2054 (the “2054 Bonds,” and collectively with the 2034 Bonds, the “Bonds”).”
POTOMAC ELECTRIC POWER CO

POTOMAC ELECTRIC POWER CO incurred senior notes of $375 million at 5.200% per annum maturing March 15, 2034.

“On March 4, 2024, Potomac Electric Power Company (Pepco) issued and sold (i) $375 million aggregate principal amount of Pepco’s First Mortgage Bonds, 5.200% Series due March 15, 2034 (the “2034 Bonds”)”
NEE NEXTERA ENERGY INC

NEXTERA ENERGY INC incurred convertible notes of $1.0 billion in aggregate principal amount with initial purchasers at 3.00% per year, payable semi-annually maturing March 1, 2027.

“On March 1, 2024, NextEra Energy Capital Holdings, Inc. (NEECH) issued $1.0 billion in aggregate principal amount of its 3.00% Exchangeable Senior Notes due 2027 (the notes) pursuant to an indenture dated as of March 1, 2024 (the indenture) among NEECH, NextEra Energy, Inc. (NEE), NEECH’s corporate parent, as guara ntor, and The Bank of New York Mellon , as trustee.”
ALNT ALLIENT INC

ALLIENT INC incurred revolving credit of up to $280 million with HSBC Bank USA, National Association, as Administrative Agent at Term SOFR Rate plus a margin of 1.25% to 2.50% or Alternative Base Rate plus a m maturing March 1, 2029.

“TD Bank, N.A. and PNC Capital Markets LLC, as Joint Lead Arrangers, and Citizens Bank, N.A., as Syndication Agent. The Revolving Facility replaced the Company’s existing $280 million revolving credit facility (the “Existing Revolving Facility”), dated as of August 23, 2022, by any among the Company, HSBC Bank USA, National Association, as Administrative”
ARES STRATEGIC INCOME FUND

ARES STRATEGIC INCOME FUND amended credit facility of from $1.2 billion to $1.4 billion with Société Générale.

“increased the total commitments under the SG Funding Facility from $1.2 billion to $1.4 billion”
DFLI Dragonfly Energy Holdings Corp.

Dragonfly Energy Holdings Corp. incurred convertible notes of $1,700,000 with Brian Nelson maturing March 1, 2024.

“On February 27, 2024, Dragonfly Energy Holdings Corp. (the “ Company ”) issued an unsecured convertible promissory note (the “ February Note ”) in the principal amount of $1,700,000 (the “ February Principal Amount ”) to Brian Nelson, a director of the Company (the “ Holder ”), in a private placement in exchange for cash in an equal amount (the “ February Private Placement ”).”
COCH Envoy Medical, Inc.

Envoy Medical, Inc. incurred loan of up to $10,000,000 with GAT Funding, LLC at 8.0% per annum maturing 2029-02-27.

“a Material Definitive Agreement Envoy Medical, Inc. (the “Company”) has issued a promissory note, effective as of February 27, 2024 (the “Note”) with a principal amount of up to $10,000,000 to GAT Funding, LLC (“GAT”), an entity controlled by Glen Taylor, who is a member of the Company’s board of directors and controlling stockholder of the Company. Upon meeting”
CORETAG, INC.

CORETAG, INC. incurred loan of $10,731.00 with Mr. Joseph Passalaqua maturing 18 month anniversary thereof.

“On March 1, 2024, the Company and Passalaqua entered into a Promissory Note relating to various loans made by Passalaqua to the Company over the period from October 1, 2023, through December 31, 2023 in the aggregate amount of $10,731.00”
CORETAG, INC.

CORETAG, INC. incurred loan of $5,820.00 with Mr. Joseph Passalaqua maturing 18 month anniversary thereof.

“On March 1, 2024, the Company and Passalaqua entered into a Promissory Note relating to various loans made by Passalaqua to the Company over the period from July 1, 2023, through September 30, 2023 in the aggregate amount of $5,820.00”
CORETAG, INC.

CORETAG, INC. incurred loan of $26,173.00 with Mr. Joseph Passalaqua maturing 18 month anniversary thereof.

“On October 16, 2023, the Company and Passalaqua entered into a Promissory Note relating to various loans made by Passalaqua to the Company over the period from October 1, 2022, through June 30, 2023 in the aggregate amount of $26,173.00”
CORETAG, INC.

CORETAG, INC. incurred loan of $14,424.00 with Mr. Joseph Passalaqua maturing 18 month anniversary thereof.

“On October 16, 2023, the Company and Passalaqua entered into a Promissory Note relating to various loans made by Passalaqua to the Company over the period from October 1, 2021, through September 30, 2022 in the aggregate amount of $14,424.00”
CHRS Coherus Oncology, Inc.

Coherus Oncology, Inc. amended term loan with Biopharma Credit PLC, BPCR Limited Partnership, Biopharma Credit Investments V (MASTER) LP.

“on February 5, 2024, the Company, as borrower and on behalf of itself and certain of its subsidiaries, entered into a Consent, Partial Release and Third Amendment to Loan Agreement (the “Consent and Amendment”) with Biopharma Credit PLC, a public limited company incorporated under the laws of England and Wales, as collateral agent (the “Collateral Agent”), BPCR Limited Partnership, a limited partnership established under the laws of England and Wales, as a lender (“BPCR”), and Biopharma Credit Investments V (MASTER) LP, a Cayman Islands exempted limited partnership acting by its general partner, BioPharma Credit Investments V GP LLC (as a lender, and together with as BPCR, each, a “Lender” and collectively, the “Lenders”), pursuant to which the Lenders and the Collateral Agent provided certain consents, and released certain assets and subsidiaries of the Company from their obligations under the Existing Loan Agreement and the other loan documents in connection therewith, and the partie”
SAFE Safehold Inc.

Safehold Inc. incurred senior notes of $300,000,000 at 6.100% per annum maturing April 1, 2034.

“On March 4, 2024, Safehold GL Holdings LLC (the “Issuer”), a Delaware limited liability company and subsidiary of Safehold Inc. (the “Guarantor” or the “Company”), completed an underwritten public offering of $300,000,000 aggregate principal amount of its 6.100% Senior Notes due 2034 (the “Notes”).”
PLCE Childrens Place, Inc.

Childrens Place, Inc. incurred term loan of up to $78.6 million in term loans with Mithaq Capital SPC at interest-free maturing February 15, 2027.

“its subsidiaries entered into an interest-free unsecured promissory note, dated February 29, 2024 (the “Promissory Note”) with Mithaq Capital SPC (“Mithaq”), providing for up to $78.6 million in term loans, consisting of (a) an initial term loan in an original aggregate principal amount of $30.0 million (the “Initial Term Loan”) and (b) a delayed draw term loan”
WYY WIDEPOINT CORP

WIDEPOINT CORP incurred revolving credit of $4,000,000 with Old Dominion National Bank at Prime Rate published in The Wall Street Journal, subject to a floor rate of 7.25 maturing February 28, 2025.

“On February 29, 2024, WidePoint Corporation and its subsidiaries (the "Company"), as borrower, entered into a Loan and Security Agreement (the "Loan") and Promissory Note (the "Note," and, together with the Loan, the "Agreements") with Old Dominion National Bank. The Agreements provide for a new $4,000,000 revolving line of credit facility (the "Credit Facility").”
WAFD WAFD INC

WAFD INC incurred senior notes of initial principal amount of $95,000,000 with Holders of Luther Burbank senior unsecured term notes at 6.50% maturing September 30, 2024.

“Luther Burbank’s 6.50% senior unsecured term notes maturing September 30, 2024, issued with an initial principal amount of $95,000,000 (the “Senior Debt”)”
WAFD WAFD INC

WAFD INC incurred senior notes of initial principal amount of $41,238,000 with Holders of Luther Burbank 2036 Notes at fixed/floating rate maturing June 15, 2036.

“Luther Burbank’s fixed/floating rate junior subordinated deferrable interest debentures due June 15, 2036, with an initial principal amount of $41,238,000, dated March 30, 2006 (the “2036 Notes”)”
SNEX StoneX Group Inc.

StoneX Group Inc. incurred senior notes of $550 million with The Bank of New York Mellon at 7.875% per annum maturing March 1, 2031.

“StoneX Group Inc. (the “Company”) completed the issuance and sale of $550 million in aggregate principal amount of its 7.875% Senior Secured Notes due 2031 (the “Notes”).”
NTRP NextTrip, Inc.

NextTrip, Inc. incurred loan of $391,776.54 with William Kerby at 7.5% simple interest per annum maturing February 28, 2025.

“o William Kerby, to memorialize the terms and conditions of certain working capital advances made by Mr.”
HON HONEYWELL INTERNATIONAL INC

HONEYWELL INTERNATIONAL INC incurred senior notes of $650,000,000 aggregate principal amount at 5.350% maturing 2064.

“On March 1, 2024, Honeywell International Inc. (the “Company”) completed public offerings of €750,000,000 aggregate principal amount of its 3.375% Senior Notes due 2030 and €750,000,000 aggregate principal amount of its 3.750% Senior Notes due 2036 (collectively, the “Euro Notes”) and $500,000,000 aggregate principal amount of its 4.875% Senior Notes due 2029, $500,000,000 aggregate principal amount of its 4.950% Senior Notes due 2031, $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2035, $1,750,000,000 aggregate principal amount of its 5.250% Senior Notes due 2054 and $650,000,000 aggregate principal amount of its 5.350% Senior Notes due 2064 (collectively, the “U.S. Notes” and, together with the Euro Notes, the “Notes”).”
HON HONEYWELL INTERNATIONAL INC

HONEYWELL INTERNATIONAL INC incurred senior notes of $1,750,000,000 aggregate principal amount at 5.250% maturing 2054.

“On March 1, 2024, Honeywell International Inc. (the “Company”) completed public offerings of €750,000,000 aggregate principal amount of its 3.375% Senior Notes due 2030 and €750,000,000 aggregate principal amount of its 3.750% Senior Notes due 2036 (collectively, the “Euro Notes”) and $500,000,000 aggregate principal amount of its 4.875% Senior Notes due 2029, $500,000,000 aggregate principal amount of its 4.950% Senior Notes due 2031, $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2035, $1,750,000,000 aggregate principal amount of its 5.250% Senior Notes due 2054 and $650,000,000 aggregate principal amount of its 5.350% Senior Notes due 2064 (collectively, the “U.S. Notes” and, together with the Euro Notes, the “Notes”).”
HON HONEYWELL INTERNATIONAL INC

HONEYWELL INTERNATIONAL INC incurred senior notes of $750,000,000 aggregate principal amount at 5.000% maturing 2035.

“On March 1, 2024, Honeywell International Inc. (the “Company”) completed public offerings of €750,000,000 aggregate principal amount of its 3.375% Senior Notes due 2030 and €750,000,000 aggregate principal amount of its 3.750% Senior Notes due 2036 (collectively, the “Euro Notes”) and $500,000,000 aggregate principal amount of its 4.875% Senior Notes due 2029, $500,000,000 aggregate principal amount of its 4.950% Senior Notes due 2031, $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2035, $1,750,000,000 aggregate principal amount of its 5.250% Senior Notes due 2054 and $650,000,000 aggregate principal amount of its 5.350% Senior Notes due 2064 (collectively, the “U.S. Notes” and, together with the Euro Notes, the “Notes”).”
HON HONEYWELL INTERNATIONAL INC

HONEYWELL INTERNATIONAL INC incurred senior notes of $500,000,000 aggregate principal amount at 4.950% maturing 2031.

“On March 1, 2024, Honeywell International Inc. (the “Company”) completed public offerings of €750,000,000 aggregate principal amount of its 3.375% Senior Notes due 2030 and €750,000,000 aggregate principal amount of its 3.750% Senior Notes due 2036 (collectively, the “Euro Notes”) and $500,000,000 aggregate principal amount of its 4.875% Senior Notes due 2029, $500,000,000 aggregate principal amount of its 4.950% Senior Notes due 2031, $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2035, $1,750,000,000 aggregate principal amount of its 5.250% Senior Notes due 2054 and $650,000,000 aggregate principal amount of its 5.350% Senior Notes due 2064 (collectively, the “U.S. Notes” and, together with the Euro Notes, the “Notes”).”
HON HONEYWELL INTERNATIONAL INC

HONEYWELL INTERNATIONAL INC incurred senior notes of $500,000,000 aggregate principal amount at 4.875% maturing 2029.

“On March 1, 2024, Honeywell International Inc. (the “Company”) completed public offerings of €750,000,000 aggregate principal amount of its 3.375% Senior Notes due 2030 and €750,000,000 aggregate principal amount of its 3.750% Senior Notes due 2036 (collectively, the “Euro Notes”) and $500,000,000 aggregate principal amount of its 4.875% Senior Notes due 2029, $500,000,000 aggregate principal amount of its 4.950% Senior Notes due 2031, $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2035, $1,750,000,000 aggregate principal amount of its 5.250% Senior Notes due 2054 and $650,000,000 aggregate principal amount of its 5.350% Senior Notes due 2064 (collectively, the “U.S. Notes” and, together with the Euro Notes, the “Notes”).”
HON HONEYWELL INTERNATIONAL INC

HONEYWELL INTERNATIONAL INC incurred senior notes of €750,000,000 aggregate principal amount at 3.750% maturing 2036.

“On March 1, 2024, Honeywell International Inc. (the “Company”) completed public offerings of €750,000,000 aggregate principal amount of its 3.375% Senior Notes due 2030 and €750,000,000 aggregate principal amount of its 3.750% Senior Notes due 2036 (collectively, the “Euro Notes”) and $500,000,000 aggregate principal amount of its 4.875% Senior Notes due 2029, $500,000,000 aggregate principal amount of its 4.950% Senior Notes due 2031, $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2035, $1,750,000,000 aggregate principal amount of its 5.250% Senior Notes due 2054 and $650,000,000 aggregate principal amount of its 5.350% Senior Notes due 2064 (collectively, the “U.S. Notes” and, together with the Euro Notes, the “Notes”).”
HON HONEYWELL INTERNATIONAL INC

HONEYWELL INTERNATIONAL INC incurred senior notes of €750,000,000 aggregate principal amount at 3.375% maturing 2030.

“On March 1, 2024, Honeywell International Inc. (the “Company”) completed public offerings of €750,000,000 aggregate principal amount of its 3.375% Senior Notes due 2030 and €750,000,000 aggregate principal amount of its 3.750% Senior Notes due 2036 (collectively, the “Euro Notes”) and $500,000,000 aggregate principal amount of its 4.875% Senior Notes due 2029, $500,000,000 aggregate principal amount of its 4.950% Senior Notes due 2031, $750,000,000 aggregate principal amount of its 5.000% Senior Notes due 2035, $1,750,000,000 aggregate principal amount of its 5.250% Senior Notes due 2054 and $650,000,000 aggregate principal amount of its 5.350% Senior Notes due 2064 (collectively, the “U.S. Notes” and, together with the Euro Notes, the “Notes”).”
GATX GATX CORP

GATX CORP incurred senior notes of $350,000,000 aggregate principal amount with BofA Securities, Inc., Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC at 5.400% maturing 2027.

“GATX agreed to sell and the Underwriters agreed to purchase, subject to and upon terms and conditions set forth therein, $350,000,000 aggregate principal amount of 5.400% Senior Notes due 2027”
SBC SBC Medical Group Holdings Inc

SBC Medical Group Holdings Inc amended convertible notes of $2,700,000 with SBC Medical Group Holdings Incorporated.

“nd SBC Medical Group Holdings Incorporated, a Delaware corporation (“ SBC ”), entered into a Note Purchase Agreement”
FLNC Fluence Energy, Inc.

Fluence Energy, Inc. incurred credit facility of $75.0 million with Credit Agricole Corporate and Investment Bank at 1.7% per annum.

“bruary 27, 2024, Fluence Energy, LLC ("Fluence"), a wholly-owned subsidiary of Fluence Energy, Inc., entered into a Master Receivables Purchase Agreement, by and among Fluence and any other seller from time to time party thereto, as sellers and servicers, and Credit Agricole Corporate and Investment Bank ("CACIB"), as purchaser (the "Agreement").”
Aquaron Acquisition Corp.

Aquaron Acquisition Corp. incurred loan of $70,000 with Bestpath IoT Technology Ltd. at does not bear interest maturing upon closing of a business combination by the Company.

“On March 1, 2024, Aquaron Acquisition Corp. (the " Company ") issued an unsecured promissory note in the aggregate principal amount of $70,000 (the " Note ") to Bestpath IoT Technology Ltd. (" Bestpath ") in exchange for Bestpath depositing such amount into the Company’s trust account in order to extend the amount of time it has available to complete a business combination.”
Focus Impact BH3 Acquisition Co

Focus Impact BH3 Acquisition Co incurred loan of up to $500,000 with Focus Impact BHAC Sponsor, LLC maturing upon closing of the Company’s initial business combination.

“On February 26, 2024, Focus Impact BHAC Acquisition Company (the “Company”) issued an unsecured promissory note in the total principal amount of up to $500,000 (the “Promissory Note”) to Focus Impact BHAC Sponsor, LLC.”
Astra Space, Inc.

Astra Space, Inc. incurred convertible notes of $300,000 in aggregate principal amount with Chris Kemp Trust and Adam London at 12.0% maturing November 15, 2025.

“the Additional Investors purchased $300,000 in aggregate principal amount of a 12.0% Senior Secured Convertible Note due 2025”
AIR AAR CORP

AAR CORP incurred revolving credit of approximately $186.2 million.

“the Company borrowed approximately $186.2 million under the Amended Revolving Credit Facility to fund a portion of the purchase price for the Triumph Group Product Support Business Acquisition”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.